SelectScience® is delighted to announce the winners of the 2017 Scientists’ Choice Awards® for Drug Discovery & Development, as chosen by scientists across the world. Winners and nominees were celebrated during a special ceremony held on February 6 at the SLAS2017 international conference and exhibition in Washington D.C., USA. Read on to discover the winners of these coveted awards and highlights from this exciting event.
The annual Scientists' Choice Awards® celebrate the laboratory products and manufacturers that make a difference to the industry. Scientists are invited to nominate, vote and review online.
Best New Product of 2016
SelectScience revealed the Bruker Daltonics rapifleX™ MALDI PharmaPulse™ as your chosen winner for Best New Drug Discovery & Development Product of 2016, as nominated and voted for by scientists around the globe.
Dr Meike Hamester, Director Small Molecule Pharma Business, Bruker Daltonik GmbH, accepted the award for Best New Drug Discovery Development Product of 2016
Do you use this system? Let us know what you think by reviewing the Bruker Daltonics rapifleX™ MALDI PharmaPulse™ today.
Best Drug Discovery Video Interview of the Year
An interview with AstraZeneca’s Vice-President of Screening Sciences and Sample Management, Steve Rees, and Principal Scientist, Jonathan Wingfield, was your chosen winner for Best Drug Discovery Video Interview. Watch the video to learn about a breakthrough workflow that combines acoustic liquid handling technology, from Labcyte Inc., and mass spectrometry to produce high quality data, increase throughput and reduce both assay development and screening costs by 100- to 1000-fold.
Best Drug Discovery & Development Article of the Year
The Scientists' Choice Award for Best Drug Discovery & Development Article was awarded to an interview with Dr Kirk McManus, Associate Professor in the Department of Biochemistry & Medical Genetics at the University of Manitoba and Senior Scientist within the Research Institute in Oncology at CancerCare Manitoba. Read the article to learn about cutting-edge cancer research using a high throughput screening workflow from BioTek Instruments, Inc. that aims to identify cancer causing genetic abnormalities and screen potential therapies.
Commenting on the award, Dr McManus told SelectScience:
“It is with great pleasure that I accept this award and honor on behalf of my research team at CancerCare Manitoba and the University of Manitoba. It was truly a pleasure to provide insight into the cancer research and high throughput screens we are performing and share this with a world-wide audience. I would also like to take this opportunity to thank Select Science, and in particular Sarah Thomas and Lynsey Forsyth, for the professional manner in which they conducted the interview and the outstanding article they produced. Finally, I would also like to thank the BioTek team, Charles Amirmansour, Chris Wilson and Brad Larson, for keeping us up and running, and assisting in the development of new and innovative screens.”
Reviewers' Choice Award for Drug Discovery & Development Product of the Year
The Reviewers' Choice Award for Drug Discovery & Development Product of the Year, which is based on the reviews published on the SelectScience website, was won by BioTek Instruments, Inc. for its Synergy™ Neo2 Multi-Mode Reader.
Visit the Scientists' Choice Awards website for more information.